A carregar...
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
The widespread coronavirus SARS-CoV-2 has already infected over 4 million people worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies mainly on antiviral drugs lopinavir/ritonavir, arbidol, and remdesivir, the anti-malarial drugs hydroxychloroquine and chloroquine...
Na minha lista:
| Publicado no: | Pharmacol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7255230/ https://ncbi.nlm.nih.gov/pubmed/32470470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2020.107587 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|